Data from various studies have reflected that China has the highest prevalence of hepatitis B virus (HBV) carriers in the world and an increasing trend in the rate of hepatitis C virus (HCV) infection.
← all excerpts
Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study.
1
—
—